• No results found

Sustained release and enteric coated NSAIDs…

AN OVERVIEW ON SUSTAINED RELEASE ENTERIC COATED TABLET OF PENTOPRAZOLE

AN OVERVIEW ON SUSTAINED RELEASE ENTERIC COATED TABLET OF PENTOPRAZOLE

... absorbed. Enteric coating refers to theminuscule intestine, therefore enteric coatings reduces release of medication before it reaches the minuscule ...Maximum enteric coatings perform by ...

7

Studies on enteric coated sustained timed release tablets of Metronidazole

Studies on enteric coated sustained timed release tablets of Metronidazole

... timed release tablets with a predetermined lag time of 4-5 ...of enteric coated tablets were prepared and there drug dissolution profile was studied in ...timed release functions could be ...

7

Formulation and Evaluation of Didanosine Enteric Coated
Sustained Release Tablet

Formulation and Evaluation of Didanosine Enteric Coated Sustained Release Tablet

... A Sustained release formulations can be utilized to avoid repetitive dosing of drugs in a day and few drugs like Didanosine incompatible with gastric juice, to avoid overcome the incompatibility of drug, ...

7

Formulation and Evaluation of Didanosine Enteric Coated Sustained Release Tablet

Formulation and Evaluation of Didanosine Enteric Coated Sustained Release Tablet

... Enteric coated tablets of Didanosine were developed to get resistance from Gastric juice when it presents in stomach, because Didanosine is incompatible with gastric ...for sustained the drug ...for ...

6

FORMULATION AND EVALUATION OF ENTERIC COATED SUSTAINED RELEASE TABLETS OF OMEPRAZOLE FOR DUODENAL ULCER

FORMULATION AND EVALUATION OF ENTERIC COATED SUSTAINED RELEASE TABLETS OF OMEPRAZOLE FOR DUODENAL ULCER

... Enteric Coatings: Oral site-specific drug delivery systems have attracted a great deal of interest recently for the treatment of a variety of bowel diseases and also for improving systemic absorption of drugs, ...

12

FORMULATION DESIGN AND OPTIMIZATION OF AN ENTERIC COATED SUSTAINED RELEASE MUCOADHESIVE TABLET OF METRONIDAZOLE

FORMULATION DESIGN AND OPTIMIZATION OF AN ENTERIC COATED SUSTAINED RELEASE MUCOADHESIVE TABLET OF METRONIDAZOLE

... a sustained release formulation anddanger of modification in drug release ...the release of drug from the dosage form are useful especially for achieving controlled plasma level of the drug as ...

6

Design and Evaluation of a Sustained Release Enteric Coated Dosage Form of Fluoxetine Hydrochloride

Design and Evaluation of a Sustained Release Enteric Coated Dosage Form of Fluoxetine Hydrochloride

... day sustained release enteric coated tablet of Fluoxetine HCl by direct compression ...as enteric coating ...Increased release rate was observed in polymer in the order HPMC K ...

10

Design and Evaluation of a Sustained Release Enteric Coated Dosage Form of Fluoxetine Hydrochloride

Design and Evaluation of a Sustained Release Enteric Coated Dosage Form of Fluoxetine Hydrochloride

... sustain release enteric coated tablet of Fluoxetine HCl by direct compression ...as enteric coating ...Drug release rate was increased in polymer order HPMC K 100M > ethyl cellulose ...

10

Formulation and Drug Release of Isoxsuprine HCL Enteric Coated Tablets

Formulation and Drug Release of Isoxsuprine HCL Enteric Coated Tablets

... evaluate enteric coated tablets using Isoxsuprine Hydrochloride as a model ...and enteric coated tablets were prepared and drug release was ...

6

Formulation and Evaluation of Delayed Release Pantoprazole Sodium Enteric Coated Tablets.

Formulation and Evaluation of Delayed Release Pantoprazole Sodium Enteric Coated Tablets.

... trihydrate enteric coated tablets were prepared to deliver drug in upper git, different tablets were prepared with super disintegrants like Ac-Di-Sol, crospovidone ,sodium starch glycolate and diluents like ...

124

FORMULATION AND CHARACTERIZATION OF SUSTAINED RELEASE COATED MATRIX GRANULES OF METFORMIN HYDROCHLORIDE

FORMULATION AND CHARACTERIZATION OF SUSTAINED RELEASE COATED MATRIX GRANULES OF METFORMIN HYDROCHLORIDE

... Results: All the formulations showed percentage yield in the range of 77.66–82.86% and drug content in the range of 78.23–96.62%. CMG3 showed drug release of 97.02% for 12 h. Fourier-transform infrared ...

6

CHITOSAN COATED ALGINATE -CARRAGEENAN PARTICULATE SYSTEMS FOR SUSTAINED RELEASE OF NAPROXEN

CHITOSAN COATED ALGINATE -CARRAGEENAN PARTICULATE SYSTEMS FOR SUSTAINED RELEASE OF NAPROXEN

... cumulative release profile ...drug release in chitosan coated alginate microspheres, can be reduced extended over the period of time considerably by adding carrageenan into the formulations, which ...

13

DEVELOPMENT OF A NOVEL ENTERIC COATED EXTENDED RELEASE PELLETS USING MODEL NSAID FLURBIPROFEN

DEVELOPMENT OF A NOVEL ENTERIC COATED EXTENDED RELEASE PELLETS USING MODEL NSAID FLURBIPROFEN

... were coated with polymer Eudragit RS30D in a coating pan to achieve a sustainable release for 12 ...abstaining release in acidic ...drug release, Kinetic studies and stability ...drug ...

7

Preparation of coated valproic acid and sodium valproate sustained-release matrix tablets

Preparation of coated valproic acid and sodium valproate sustained-release matrix tablets

... or sustained release formulations, the diffusion, swelling and erosion were the three most important rate-controlling ...drug release from the polymeric system was mostly occurred by diffusion and ...

11

Cataflam diclofenac potassium Immediate-Release Tablets. Voltaren diclofenac sodium Delayed-Release (enteric-coated) Tablets

Cataflam diclofenac potassium Immediate-Release Tablets. Voltaren diclofenac sodium Delayed-Release (enteric-coated) Tablets

... plasma levels of approximately 40%. The extent of absorption of diclofenac, however, is not significantly affected by food intake. Voltaren-XR Extended-Release Tablets: The extent of diclofenac absorption from the ...

20

Directly compressed mini-tablets coated in a solid-wall pan for sustained drug release

Directly compressed mini-tablets coated in a solid-wall pan for sustained drug release

... Sustained release was ensur- ed by both formulae and all polymer amounts, proportionate to the coating level. At the same coating level, the dissolution pro- files of both formulae were not significantly ...

5

Formulation and Evaluation of Bisacodyl Enteric Coated Tablets

Formulation and Evaluation of Bisacodyl Enteric Coated Tablets

... LITERATURE REVIEW that the Guar Gum, Xanthan Gum and Ethyl cellulose and Sodium alginate at minimum concentration is not only able to sustain but also control the drug release. ● Gushit, J. S et al ., (2010), ...

147

Formulation and Evaluation of Enteric Coated Tablets of Pantoprazole

Formulation and Evaluation of Enteric Coated Tablets of Pantoprazole

... were coated using enteric coating polymer such as cellulose acetate phthalate, Eudragit L100 and by dip coating ...vitro release was studied using acidic buffer pH ...

101

Formulation and Evaluation of Lansoprazole Enteric Coated Pellets

Formulation and Evaluation of Lansoprazole Enteric Coated Pellets

... of enteric coated sodium valproate pellets was ...USP enteric test, the solution-layered and wet-mass extruded pellets required 35 and 25% weight gain of EudragitL 30D-55, ...valproate release ...

132

Formulation and evaluation of enteric coated tablet of Ilaprazole

Formulation and evaluation of enteric coated tablet of Ilaprazole

... Enteric coated tablet of EC1 shows less resistance in ...and release more than 5% ...not release more than 5% ...other enteric coated batches. So, enteric coating formula ...

5

Show all 10000 documents...

Related subjects